Cargando…

Current status of integrating oncology and palliative care in Japan: a nationwide survey

BACKGROUND: Palliative care (PC) is increasingly recognized as essential for oncology care, and several academic societies strongly recommend integrating oncology and palliative care (IOP) in daily practice. Similarly, the Japanese government encouraged the implementation of IOP through the Cancer C...

Descripción completa

Detalles Bibliográficos
Autores principales: Uneno, Y., Sato, K., Morita, T., Nishimura, M., Ito, S., Mori, M., Shimizu, C., Horie, Y., Hirakawa, M., Nakajima, T. E., Tsuneto, S., Muto, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6982384/
https://www.ncbi.nlm.nih.gov/pubmed/31980015
http://dx.doi.org/10.1186/s12904-020-0515-5
_version_ 1783491301790973952
author Uneno, Y.
Sato, K.
Morita, T.
Nishimura, M.
Ito, S.
Mori, M.
Shimizu, C.
Horie, Y.
Hirakawa, M.
Nakajima, T. E.
Tsuneto, S.
Muto, M.
author_facet Uneno, Y.
Sato, K.
Morita, T.
Nishimura, M.
Ito, S.
Mori, M.
Shimizu, C.
Horie, Y.
Hirakawa, M.
Nakajima, T. E.
Tsuneto, S.
Muto, M.
author_sort Uneno, Y.
collection PubMed
description BACKGROUND: Palliative care (PC) is increasingly recognized as essential for oncology care, and several academic societies strongly recommend integrating oncology and palliative care (IOP) in daily practice. Similarly, the Japanese government encouraged the implementation of IOP through the Cancer Control Act of 2007; however, its detailed progress remains unclear. Therefore, this cross-sectional nationwide survey was conducted to investigate the current status and hospital executive physicians’ perception of IOP. METHODS: The questionnaire was developed based on IOP indicators with international consensus. It was distributed to executive physicians at all government-designated cancer hospitals (DCHs, n = 399) and matched non-DCHs (n = 478) in November 2017 and the results were compared. RESULTS: In total, 269 (67.4%) DCHs and 259 (54.2%) non-DCHs responded. The number of PC resources in DCHs was significantly higher than those in non-DCHs (e.g., full-time PC physicians and nurses, 52.8% vs. 14.0%, p < 0.001; availability of outpatient PC service ≥3 days per week, 47.6% vs. 20.7%, p < 0.001). Routine symptom screening was more frequently performed in DCHs than in non-DCHs (65.1% vs. 34.7%, p < 0.001). Automatic trigger for PC referral availability was limited (e.g., referral using time trigger, 14.9% vs. 15.3%, p = 0.700). Education and research opportunities were seriously limited in both types of hospitals. Most executive physicians regarded IOP as beneficial for their patients (95.9% vs. 94.7%, p = 0.163) and were willing to facilitate an early referral to PC services (54.7% vs. 60.0%, p < 0.569); however, the majority faced challenges to increase the number of full-time PC staff, and < 30% were planning to increase the staff members. CONCLUSIONS: This survey highlighted a considerable number of IOP indicators met, particularly in DCHs probably due to the government policy. Further efforts are needed to address the serious research/educational gaps.
format Online
Article
Text
id pubmed-6982384
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-69823842020-01-29 Current status of integrating oncology and palliative care in Japan: a nationwide survey Uneno, Y. Sato, K. Morita, T. Nishimura, M. Ito, S. Mori, M. Shimizu, C. Horie, Y. Hirakawa, M. Nakajima, T. E. Tsuneto, S. Muto, M. BMC Palliat Care Research Article BACKGROUND: Palliative care (PC) is increasingly recognized as essential for oncology care, and several academic societies strongly recommend integrating oncology and palliative care (IOP) in daily practice. Similarly, the Japanese government encouraged the implementation of IOP through the Cancer Control Act of 2007; however, its detailed progress remains unclear. Therefore, this cross-sectional nationwide survey was conducted to investigate the current status and hospital executive physicians’ perception of IOP. METHODS: The questionnaire was developed based on IOP indicators with international consensus. It was distributed to executive physicians at all government-designated cancer hospitals (DCHs, n = 399) and matched non-DCHs (n = 478) in November 2017 and the results were compared. RESULTS: In total, 269 (67.4%) DCHs and 259 (54.2%) non-DCHs responded. The number of PC resources in DCHs was significantly higher than those in non-DCHs (e.g., full-time PC physicians and nurses, 52.8% vs. 14.0%, p < 0.001; availability of outpatient PC service ≥3 days per week, 47.6% vs. 20.7%, p < 0.001). Routine symptom screening was more frequently performed in DCHs than in non-DCHs (65.1% vs. 34.7%, p < 0.001). Automatic trigger for PC referral availability was limited (e.g., referral using time trigger, 14.9% vs. 15.3%, p = 0.700). Education and research opportunities were seriously limited in both types of hospitals. Most executive physicians regarded IOP as beneficial for their patients (95.9% vs. 94.7%, p = 0.163) and were willing to facilitate an early referral to PC services (54.7% vs. 60.0%, p < 0.569); however, the majority faced challenges to increase the number of full-time PC staff, and < 30% were planning to increase the staff members. CONCLUSIONS: This survey highlighted a considerable number of IOP indicators met, particularly in DCHs probably due to the government policy. Further efforts are needed to address the serious research/educational gaps. BioMed Central 2020-01-24 /pmc/articles/PMC6982384/ /pubmed/31980015 http://dx.doi.org/10.1186/s12904-020-0515-5 Text en © The Author(s). 2020 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Uneno, Y.
Sato, K.
Morita, T.
Nishimura, M.
Ito, S.
Mori, M.
Shimizu, C.
Horie, Y.
Hirakawa, M.
Nakajima, T. E.
Tsuneto, S.
Muto, M.
Current status of integrating oncology and palliative care in Japan: a nationwide survey
title Current status of integrating oncology and palliative care in Japan: a nationwide survey
title_full Current status of integrating oncology and palliative care in Japan: a nationwide survey
title_fullStr Current status of integrating oncology and palliative care in Japan: a nationwide survey
title_full_unstemmed Current status of integrating oncology and palliative care in Japan: a nationwide survey
title_short Current status of integrating oncology and palliative care in Japan: a nationwide survey
title_sort current status of integrating oncology and palliative care in japan: a nationwide survey
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6982384/
https://www.ncbi.nlm.nih.gov/pubmed/31980015
http://dx.doi.org/10.1186/s12904-020-0515-5
work_keys_str_mv AT unenoy currentstatusofintegratingoncologyandpalliativecareinjapananationwidesurvey
AT satok currentstatusofintegratingoncologyandpalliativecareinjapananationwidesurvey
AT moritat currentstatusofintegratingoncologyandpalliativecareinjapananationwidesurvey
AT nishimuram currentstatusofintegratingoncologyandpalliativecareinjapananationwidesurvey
AT itos currentstatusofintegratingoncologyandpalliativecareinjapananationwidesurvey
AT morim currentstatusofintegratingoncologyandpalliativecareinjapananationwidesurvey
AT shimizuc currentstatusofintegratingoncologyandpalliativecareinjapananationwidesurvey
AT horiey currentstatusofintegratingoncologyandpalliativecareinjapananationwidesurvey
AT hirakawam currentstatusofintegratingoncologyandpalliativecareinjapananationwidesurvey
AT nakajimate currentstatusofintegratingoncologyandpalliativecareinjapananationwidesurvey
AT tsunetos currentstatusofintegratingoncologyandpalliativecareinjapananationwidesurvey
AT mutom currentstatusofintegratingoncologyandpalliativecareinjapananationwidesurvey